Germany’s Bayer says it plans to buy Merck & Co’s consumer care business for $14.2 billion

Germany's Bayer says it plans to buy Merck & Co's consumer care business for $14.2 billion | iNFOnews.ca
AppleMark

BERLIN – Germany’s Bayer AG says it plans to buy U.S. pharmaceutical company Merck & Co. Inc.’s consumer care business, whose products include the Coppertone suncare range, Claritin allergy medicine and the Dr. Scholl’s footcare products, for $14.2 billion.

Bayer CEO Marijn Dekkers said Tuesday that the planned acquisition “marks a major milestone on our path towards global leadership in the attractive non-prescription medicines business.”

Bayer said that it also has entered an agreement with Merck to co-operate on developing potential cardiovascular treatments, with Merck initially paying Bayer $1 billion and further payments contingent on sales.

News from © The Associated Press, . All rights reserved.
This material may not be published, broadcast, rewritten or redistributed.

Join the Conversation!

Want to share your thoughts, add context, or connect with others in your community?

Create a free account

The Associated Press

The Associated Press is an independent global news organization dedicated to factual reporting. Founded in 1846, AP today remains the most trusted source of fast, accurate, unbiased news in all formats and the essential provider of the technology and services vital to the news business. More than half the world’s population sees AP journalism every day.

Related Articles